O-Trimethyl GFT-505 is an intermediate in synthesizing GFT-505 (G368870), which is adualPPARα/δ agonist. Studies have shown that GFT-505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects. It may also be a potential new drug candidate for treating lipid and glucose disorders.